How many insider declarations has Ruffolo, John filed?

Ruffolo, John has filed 4 public insider declarations with SEDI.

What is Ruffolo, John's role?

Ruffolo, John's reported role is not specified by the regulator across the filings.

Which companies does Ruffolo, John report trades for?

Ruffolo, John reports trades for NervGen Pharma Corp..

What is Ruffolo, John's declared buy vs sell volume?

Across the available history, declared buys total 12k€ and disposals 0.

← Executives ★ Sign in to follow

RJ

Ruffolo, John

OFFICER

·SEDI

NervGen Pharma Corp.

Cumul. flow

0

Total declarations

0

Company

€11,552

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Ruffolo, John. Insider active across 1 company, notably NervGen Pharma Corp.. In total, 4 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €12k. History available since 27 May 2026. The latest transaction was disclosed on 28 July 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. All data is free.

Companies and markets linked to Ruffolo, John

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

NervGen Pharma Corp. (CA)

Declarations4 total

▲

Ruffolo, John

4 - Director of IssuerExecutives28 Jul 2026NervGen Pharma Corp.

CA$3280SEDI ↗

200 shares@ CA$1.64Common SharesTSXSEDI:4759712

Canonical exit: 26 Oct 2026 (T+90)

●

Ruffolo, John

4 - Director of IssuerExecutives16 Oct 2023NervGen Pharma Corp.

0SEDI ↗

Common SharesTSXSEDI:4759711

▲

Ruffolo, John

4 - Director of IssuerExecutives27 May 2026NervGen Pharma Corp.

CA$3315SEDI ↗

16 shares@ CA$2.07620.2% of flowCommon SharesTSXSEDI:4725857

Canonical exit: 25 Aug 2026 (T+90)

▲

Ruffolo, John

4 - Director of IssuerExecutives27 May 2026NervGen Pharma Corp.

CA$18,23423SEDI ↗

8,775 shares@ CA$2.07899.8% of flowCommon SharesTSXSEDI:4725855

Canonical exit: 25 Aug 2026 (T+90)

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

RJ

Ruffolo, John

OFFICER

·SEDI

NervGen Pharma Corp.

Cumul. flow

0

Total declarations

0

Company

€11,552

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Ruffolo, John. Insider active across 1 company, notably NervGen Pharma Corp.. In total, 4 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €12k. History available since 27 May 2026. The latest transaction was disclosed on 28 July 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. All data is free.